Accelerate your clinical development: accelerator mass spectometer
other
The development of new medicines is a costly and time consuming process. One way to increase the effi ciency of drug development pipelines is by using microtracer dosing. Microtracing is an innovative technology in which very small quantities of substances are tested in humans at a very early stage of development. No more than 100 micrograms, or 30 nmoles for proteins, are administered. This is less than one hundredth of the expected therapeutic dose, a quantity that does not cause side-effects.
TNO Identifier
871584
Publisher
TNO
Collation
2 p.
Place of publication
Zeist